These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 48804

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of chloramphenicol on human bone marrow].
    Chyliński J.
    Pol Tyg Lek; 1971 Apr 26; 26(17):650-1. PubMed ID: 4933493
    [No Abstract] [Full Text] [Related]

  • 4. Chloramphenicol-induced bone marrow suppression.
    Yunis AA.
    Semin Hematol; 1973 Jul 26; 10(3):225-34. PubMed ID: 4577646
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Drug-induced bone marrow aplasia.
    Yunis AA.
    Rev Bras Pesqui Med Biol; 1978 Oct 26; 11(4-5):287-95. PubMed ID: 725142
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Why still prescribe chloramphenicol in 1983? Comparison of the clinical and biological hematologic effects of chloramphenicol and thiamphenicol.
    Baumelou E, Najean Y.
    Blut; 1983 Dec 26; 47(6):317-20. PubMed ID: 6652243
    [No Abstract] [Full Text] [Related]

  • 10. Drug-induced panmyelopathy (aplastic anaemia).
    Nieweg HO, van der Schans GS.
    Haematol Blood Transfus; 1978 Dec 26; 21():171-8. PubMed ID: 367892
    [No Abstract] [Full Text] [Related]

  • 11. Residual marrow damage: possible explanation for idiosyncrasy to chloramphenicol.
    Morley A, Trainor K, Remes J.
    Br J Haematol; 1976 Apr 26; 32(4):525-31. PubMed ID: 1259934
    [Abstract] [Full Text] [Related]

  • 12. [Acquired panmyelopathies].
    Keiser G.
    Schweiz Med Wochenschr; 1970 Nov 14; 100(46):1938-48. PubMed ID: 5507832
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Effects of chloramphenicol (CP) on in vitro colony-forming cell (CFU-C) in W anemic mice (author's transl)].
    Kanamaru A, Kosaki M, Kai T, Kashitani Y, Nagai K.
    Nihon Ketsueki Gakkai Zasshi; 1976 Dec 14; 39(6):815-20. PubMed ID: 1037460
    [No Abstract] [Full Text] [Related]

  • 15. Chloramphenicol toxicity: pathogenetic mechanisms and the role of the p-NO2 in aplastic anemia.
    Yunis AA, Miller AM, Salem Z, Arimura GK.
    Clin Toxicol; 1980 Oct 14; 17(3):359-73. PubMed ID: 7004763
    [No Abstract] [Full Text] [Related]

  • 16. Letter: Prescribing of chloramphenicol.
    Vance MA, Millington WR.
    Ann Intern Med; 1976 Jul 14; 85(1):125. PubMed ID: 937910
    [No Abstract] [Full Text] [Related]

  • 17. [Hepatitis-aplastic anemia syndrome (after the administration of chloramphenicol) (author's transl)].
    Ito M, Fukuiya Y.
    Rinsho Ketsueki; 1974 Sep 14; 15(9):985-92. PubMed ID: 4612200
    [No Abstract] [Full Text] [Related]

  • 18. Bone marrow depression due to mianserin, phenylbutazone, oxyphenbutazone, and chloramphenicol--Part II.
    Chaplin S.
    Adverse Drug React Acute Poisoning Rev; 1986 Sep 14; 5(3):181-96. PubMed ID: 3538824
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Four additional cases of aplastic anemia following chloramphenicol therapy].
    Speck B, Moeschlin S.
    Schweiz Med Wochenschr; 1969 Jun 14; 99(25):910-4. PubMed ID: 4241791
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.